Cost-effectiveness analysis of tumor molecular classification in high-risk early-stage endometrial cancer

2021 ◽  
Author(s):  
T.J. Orellana ◽  
H. Kim ◽  
S. Beriwal ◽  
R. Bhargava ◽  
J. Berger ◽  
...  
Keyword(s):  
Endometrial Cancer ◽  
Cost Effectiveness ◽  
High Risk ◽  
Early Stage ◽  
Molecular Classification ◽  
Cost Effectiveness Analysis ◽  
Effectiveness Analysis ◽  
Early Stage Endometrial Cancer

Does obesity influence the preferred treatment approach for early-stage cervical cancer? A cost-effectiveness analysis

2021 ◽  
Vol 162 ◽  
pp. S142
Author(s):  
Jacqueline Bohn ◽  
Miriam Hernandez-Zepeda ◽  
Alyssa Hersh ◽  
Elizabeth Munro ◽  
Jenna Kahn ◽  
...  
Keyword(s):  
Cervical Cancer ◽  
Cost Effectiveness ◽  
Treatment Approach ◽  
Early Stage ◽  
Cost Effectiveness Analysis ◽  
Effectiveness Analysis ◽  
Early Stage Cervical Cancer

Defining optimal adjuvant treatment for high-risk early-stage endometrial cancer

2021 ◽  
Vol 162 ◽  
pp. S123-S124
Author(s):  
Olivia Khouri ◽  
Anne Van Arsdale ◽  
Nicole Vilardo ◽  
Divya Gowthaman ◽  
Gregory Gressel ◽  
...  
Keyword(s):  
Endometrial Cancer ◽  
High Risk ◽  
Adjuvant Treatment ◽  
Early Stage ◽  
Early Stage Endometrial Cancer

Lenvatinib plus pembrolizumab in advanced recurrent endometrial cancer: A cost-effectiveness analysis

2021 ◽  
Author(s):  
David A. Barrington ◽  
Paulina J. Haight ◽  
Cody Calhoun ◽  
Crystal Tubbs ◽  
David E. Cohn ◽  
...  
Keyword(s):  
Endometrial Cancer ◽  
Cost Effectiveness ◽  
Cost Effectiveness Analysis ◽  
Effectiveness Analysis ◽  
Recurrent Endometrial Cancer
Sign in / Sign up

Export Citation Format

Share Document